Surge announces closing of a €7.5 million fundraising round to decrypt the immune system and transform precision medicine

Contributed by: Business Wire

Logo

Business Wire logo

Tags

Technology
Biotechnology
Health
Finance
Professional Services
Artificial Intelligence
Other Science
Research
Managed Care
General Health
Hospitals
Health Technology
Science
Clinical Trials
funding

More Like This

PR Newswire associated0

Cure51 raises a €15 million seed round to harness the natural power of cancer survivors and contribute to cure this life threatening disease

PR Newswire associated0

AZmed Secures €15 Million to Shape the Future of Medical Imaging with AI

Business Wire logo

Seroba Announces Above Target Final Close of its Fund IV at €123M ($134M)

Edward Kliphuis, Partner, Sofinnova Digital Medicine Strategy and Simon Turner, Partner, Sofinnova Digital Medicine Strategy (Photo: Sofinnova Partners)

Sofinnova Partners Raises $200M Digital Medicine Fund

PR Newswire associated0

Aignostics Secures $34 Million Series B to Enhance Precision Medicine with AI

PR Newswire associated0

ThinkCyte expands product portfolio to drive innovation in drug discovery and disease research.

Sequentia Biotech Secures €10million Equity Investment from Seventure Partners and the EIC Fund to Boost Bioinformatic Solutions for clinical, industrial and research applications (Graphic: Sequentia Biotech)

Sequentia Biotech Secures €10million Equity Investment from Seventure Partners and the EIC Fund to Boost Bioinformatic Solutions for Clinical, Industrial and Research Applications

PR Newswire associated0

Supira Medical Secures $120M Oversubscribed Series E Financing and Completes Enrollment of SUPPORT I Early Feasibility Study in the United States